Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of PhoenixBio Co.,Ltd.. A complete text table follows the diagram.
Low direct costs create a large gross-profit pool, but overhead leaves only a narrow operating surplus.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Cost of sales | 1 | 181M | 24.0% of reported total |
| Gross profit | 1 | 575M | 76.0% of reported total |
| Other & rounding | 1 | 0 | 0.0% of reported total |
| Biotech sales converted into gross profit | 2 | 756M | Reported six-month total · ¥756M |
| Operating profit | 3 | 5.7M | 0.8% operating margin |
| Operating costs & expenses | 3 | 751M | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 16.4M | Reported pretax result |
| PhoenixBio turns ¥756.352m of sales into ¥574.911m of gross profit | 3 | 10.7M | SG&A was ¥569.234m, leaving ¥5.676m of operating income. |
| Net profit attributable to owners | 5 | 12.3M | Reported parent-company result |
| Tax, attribution & other | 5 | 4.1M | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Cost of sales | Biotech sales converted into gross profit | 181M |
| Gross profit | Biotech sales converted into gross profit | 575M |
| Other & rounding | Biotech sales converted into gross profit | 0 |
| Biotech sales converted into gross profit | Operating profit | 5.7M |
| Biotech sales converted into gross profit | Operating costs & expenses | 751M |
| Operating profit | Profit before tax | 5.7M |
| PhoenixBio turns ¥756.352m of sales into ¥574.911m of gross profit | Profit before tax | 10.7M |
| Profit before tax | Net profit attributable to owners | 12.3M |
| Profit before tax | Tax, attribution & other | 4.1M |